[Evaluation of the drug consumption of old people. Methodologic difficulties]

Pharmacokinetic and pharmacodynamic variability of fluindione in octogenarians.

Clinical pharmacology and therapeutics·2012

Early detection of patients in the pre demented stage of Alzheimer's disease: the Pre-Al Study.

The journal of nutrition, health & aging·2009

Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study.

Neurology·2007

[Cholinesterase inhibitor therapy in long term care settings].

La Revue de medecine interne·2006

Cerebrospinal fluid MR dynamics and risk of falls in the elderly.

Journal of neuroradiology = Journal de neuroradiologie·2005

Compassionate use of quinacrine in Creutzfeldt-Jakob disease fails to show significant effects.

Neurology·2004

[Five years of ISO 9001 certification in pharmacotoxicology: Experience feedback and implementation modalities in vigilance structures].

Therapie·2026

Epidemiology and risk factors of severe cutaneous drug reactions and evaluation through available databases.

Therapie·2026

Characteristics of patients with opioid/benzodiazepine use disorder in a specialized consultation unit for prescription drug addiction: A cross-sectional study.

Therapie·2026

Anhedonia and neuropsychotropics: A pharmacovigilance-pharmacodynamic study.

Therapie·2026

[Biological pharmacology: A white paper].

Therapie·2026

Pharmacology of pruritus (pathophysiology, therapeutic targets).

Therapie·2026

Factors Influencing Physician Prescribing Practices for Overactive Bladder Pharmacotherapy: A Systematic Review.

Neurourology and urodynamics·2026

Optimizing efficacy to safety ratio of glucocorticoids in rheumatoid arthritis models by leveraging PPARα agonism.

Arthritis & rheumatology (Hoboken, N.J.)·2026

Effect of obesity on pharmacokinetics and drug dosing of remimazolam in patients with obstructive sleep apnoea.

Anaesthesia·2026

Dose Exploration Based on Quantitative Pharmacokinetic Analysis of Monoclonal Antibodies for Pediatric Immune-Mediated Diseases: Current Evidence and Future Directions.

Drug design, development and therapy·2026

Association Between CYP450 Polymorphisms and Treatment Outcomes of Escitalopram and Venlafaxine in Patients with Post Stroke Depression.

Neuropsychiatric disease and treatment·2026

A Physiologically-Based Pharmacokinetic Model to Predict Posaconazole Suspension Exposure and Optimize Dosing Strategy in Pediatric Hematology Patients: Incorporating the Impact of Food Intake.

Drug design, development and therapy·2026

Related Experiment Videos

[Evaluation of the drug consumption of old people. Methodologic difficulties]

Related Concept Videos

Pharmacokinetic and pharmacodynamic variability of fluindione in octogenarians.

Early detection of patients in the pre demented stage of Alzheimer's disease: the Pre-Al Study.

Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study.

[Cholinesterase inhibitor therapy in long term care settings].

Cerebrospinal fluid MR dynamics and risk of falls in the elderly.

Compassionate use of quinacrine in Creutzfeldt-Jakob disease fails to show significant effects.

[Five years of ISO 9001 certification in pharmacotoxicology: Experience feedback and implementation modalities in vigilance structures].

Epidemiology and risk factors of severe cutaneous drug reactions and evaluation through available databases.

Characteristics of patients with opioid/benzodiazepine use disorder in a specialized consultation unit for prescription drug addiction: A cross-sectional study.

Anhedonia and neuropsychotropics: A pharmacovigilance-pharmacodynamic study.

[Biological pharmacology: A white paper].

Pharmacology of pruritus (pathophysiology, therapeutic targets).

Factors Influencing Physician Prescribing Practices for Overactive Bladder Pharmacotherapy: A Systematic Review.

Optimizing efficacy to safety ratio of glucocorticoids in rheumatoid arthritis models by leveraging PPARα agonism.

Effect of obesity on pharmacokinetics and drug dosing of remimazolam in patients with obstructive sleep apnoea.

Dose Exploration Based on Quantitative Pharmacokinetic Analysis of Monoclonal Antibodies for Pediatric Immune-Mediated Diseases: Current Evidence and Future Directions.

Association Between CYP450 Polymorphisms and Treatment Outcomes of Escitalopram and Venlafaxine in Patients with Post Stroke Depression.

A Physiologically-Based Pharmacokinetic Model to Predict Posaconazole Suspension Exposure and Optimize Dosing Strategy in Pediatric Hematology Patients: Incorporating the Impact of Food Intake.

Related Experiment Videos

[Evaluation of the drug consumption of old people. Methodologic difficulties]

Related Concept Videos

Related Articles